A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
Clinical trial NCT05059236 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05059236
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2025-05-30
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.